Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts

By: via Benzinga
Biotech stocks had a somber performance in August, as they reacted to earnings news flow, FDA decisions and M&A news, among other ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.